Skip to main content
. 2023 Jan 9;12(2):262. doi: 10.3390/cells12020262

Figure 3.

Figure 3

Detection of SARS-CoV-2 proteins in liver samples. Immunohistochemistry for SARS-CoV-2 Nucleocapsid shows robust immunoreactivity in hepatocytes, in areas of liver damage (Panel (A) original magnification 100× and Panel (C) original magnification 400×). Spike protein is also present in the cytoplasm of hepatocytes in areas of necrosis (Panel (B) original magnification 100×, and steatosis (Panel (D) original magnification 400×).